Glucocorticoid receptor function possibly modulates cell-cell interactions in osteoblastic metastases on rat skeleton

Area of Science:

• Endocrinology
• Cancer Biology
• Cell Biology

Background:

• Glucocorticoid receptor (GR) plays a role in cellular processes.
• Understanding GR function in cancer and bone interactions is crucial.
• PA-III prostate cancer and UMR 106 osteosarcoma cells provide an in vitro model.

Purpose of the Study:

• To analyze glucocorticoid receptor (GR) function in modulating cell-cell interactions.
• To investigate the roles of transforming growth factor beta 1 (TGFbeta1), insulin-like growth factor I (IGF-I), and urokinase-type plasminogen activator (uPA) in these interactions.
• To model GR function in prostate cancer-induced bone reactions.

Main Methods:

• Ligand binding assays, DNA band-shift, and reporter gene assays (CAT) were used to detect GR.
• Cell proliferation was assessed following treatment with dexamethasone, TGFbeta1, IGF-I, and conditioned media.
• mRNA expression of TGFbeta1 and uPA was analyzed using quantitative methods.

Main Results:

• Dexamethasone and TGFbeta1 inhibited PA-III and UMR 106 cell growth, an effect reversed by anti-TGFbeta1 and IGF-I.
• IGF-I, uPA, and conditioned media from both cell lines stimulated proliferation.
• Dexamethasone modulated TGFbeta1 and uPA mRNA in PA-III cells but not UMR 106 cells.

Conclusions:

• TGFbeta1, uPA, and IGF-I are key mediators of cell-cell interactions.
• These factors play a significant role in glucocorticoid receptor (GR) function.
• The study provides insights into GR-mediated processes in prostate cancer and bone microenvironments.